Bortezomib

cyclin-dependent kinase inhibitor 1A (P21) ; Mus musculus







8 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31138526 Bortezomib Stabilizes and Activates p53 in Proliferative Compartments of Both Normal and Tumor Tissues In Vivo. 2019 Jul 15 1
2 26804704 Induction of cell death by the novel proteasome inhibitor marizomib in glioblastoma in vitro and in vivo. 2016 Jan 25 1
3 22559167 Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model. 2012 May 4 1
4 20495354 Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer. 2010 Jul 1 1
5 19458122 The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury. 2009 Aug 1
6 19020781 Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade. 2008 Dec 2
7 15217971 The potential role of proteasome inhibitors in the treatment of lung cancer. 2004 Jun 15 1
8 10363983 Proteasome inhibitors: a novel class of potent and effective antitumor agents. 1999 Jun 1 1